Patent · US Active

Fused heterocyclic mescaline derivatives

US12428408B2 · kind B2 · utility

0Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2023
Grant dateSep 30, 2025
Priority date
Expiry dateAug 4, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed are novel fused heterocyclic mescaline derivative compounds, notably fused heterocyclic mescaline derivatives and pharmaceutical and recreational drug formulations containing the same. Methods of making and using these compounds are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.